197 related articles for article (PubMed ID: 34929704)
21. Negative pressure dressings for severe hidradenitis suppurativa (acne inversa): a case report.
Walls B; Mohammad S; Campbell J; Archer L; Beale J
J Wound Care; 2010 Oct; 19(10):457-60. PubMed ID: 20948495
[TBL] [Abstract][Full Text] [Related]
22. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
[TBL] [Abstract][Full Text] [Related]
23. Financial toxicity of hidradenitis suppurativa: A single-center experience at an urban wound-care clinic.
Towfighi P; Huffman SS; Bovill JD; Shan HD; Haffner ZK; Kim EY; Slamin R; Benedict CD; Evans KK
J Dermatol; 2023 Oct; 50(10):1279-1286. PubMed ID: 37501527
[TBL] [Abstract][Full Text] [Related]
24. Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa-Part II: Procedural and Wound Care Therapies.
Fragoso NM; Masson R; Gillenwater TJ; Shi VY; Hsiao JL
Dermatol Ther (Heidelb); 2023 Aug; 13(8):1699-1720. PubMed ID: 37402030
[TBL] [Abstract][Full Text] [Related]
25. A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial.
Schultheis M; Staubach P; Nikolakis G; Schollenberger L; Mauch M; Burckhardt M; Heise M; Zamsheva M; Strobel A; Langer G; Bechara F; Kirschner U; Hennig K; Kunte C; Goebeler M; Grabbe S
Br J Dermatol; 2023 Jul; 189(2):170-179. PubMed ID: 37132470
[TBL] [Abstract][Full Text] [Related]
26. Negative-pressure dressings in the treatment of hidradenitis suppurativa.
Elwood ET; Bolitho DG
Ann Plast Surg; 2001 Jan; 46(1):49-51. PubMed ID: 11192034
[TBL] [Abstract][Full Text] [Related]
27. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
[TBL] [Abstract][Full Text] [Related]
28. The financial and quality-of-life cost to patients living with a chronic wound in the community.
Kapp S; Santamaria N
Int Wound J; 2017 Dec; 14(6):1108-1119. PubMed ID: 28635188
[TBL] [Abstract][Full Text] [Related]
29. Hidradenitis Suppurativa (Hurley I/II): Serial Excisions with Primary Wound Closure Under Local Anesthesia As Most Adequate Treatment Approach.
Tchernev G; Temelkova I
Open Access Maced J Med Sci; 2019 Feb; 7(3):400-402. PubMed ID: 30834010
[TBL] [Abstract][Full Text] [Related]
30. The Handicap of Hidradenitis Suppurativa.
Deckers IE; Kimball AB
Dermatol Clin; 2016 Jan; 34(1):17-22. PubMed ID: 26617353
[TBL] [Abstract][Full Text] [Related]
31. Single use negative-pressure wound therapy compared to standard care in patients after carbon dioxide laser surgery for hidradenitis suppurativa.
Grimstad Ø
Dermatol Ther; 2022 Jun; 35(6):e15483. PubMed ID: 35373495
[TBL] [Abstract][Full Text] [Related]
32. Dressings management of chronic wounds in patients with hidradenitis suppurativa.
Hew AS; Rashidghamat E
Clin Exp Dermatol; 2021 Dec; 46(8):1573-1574. PubMed ID: 34048093
[No Abstract] [Full Text] [Related]
33. The Broad-Spectrum Impact of Hidradenitis Suppurativa on Quality of Life: A Comparison with Psoriasis.
Sampogna F; Fania L; Mazzanti C; Caggiati A; Pallotta S; Panebianco A; Mastroeni S; Didona B; Pintori G; Abeni D
Dermatology; 2019; 235(4):308-314. PubMed ID: 31121589
[TBL] [Abstract][Full Text] [Related]
34. Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project.
Garg A; Neuren E; Cha D; Kirby JS; Ingram JR; Jemec GBE; Esmann S; Thorlacius L; Villumsen B; Marmol VD; Nassif A; Delage M; Tzellos T; Moseng D; Grimstad Ø; Naik H; Micheletti R; Guilbault S; Miller AP; Hamzavi I; van der Zee H; Prens E; Kappe N; Ardon C; Kirby B; Hughes R; Zouboulis CC; Nikolakis G; Bechara FG; Matusiak L; Szepietowski J; Glowaczewska A; Smith SD; Goldfarb N; Daveluy S; Avgoustou C; Giamarellos-Bourboulis E; Cohen S; Soliman Y; Brant EG; Akilov O; Sayed C; Tan J; Alavi A; Lowes MA; Pascual JC; Riad H; Fisher S; Cohen A; Paek SY; Resnik B; Ju Q; Wang L; Strunk A
J Am Acad Dermatol; 2020 Feb; 82(2):366-376. PubMed ID: 31279015
[TBL] [Abstract][Full Text] [Related]
35. The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities.
Bettoli V; Pasquinucci S; Caracciolo S; Piccolo D; Cazzaniga S; Fantini F; Binello L; Pintori G; Naldi L
J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):1965-1970. PubMed ID: 27136185
[TBL] [Abstract][Full Text] [Related]
36. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
[TBL] [Abstract][Full Text] [Related]
37. [Postoperative wound care with custom-made wound dressings for hidradenitis suppurativa : Wound care after radical excision with secondary wound closure].
Gasslitter I; Häfner HM; Kofler K; Kofler L
Dermatologie (Heidelb); 2022 Dec; 74(12):994-996. PubMed ID: 37910227
[TBL] [Abstract][Full Text] [Related]
38. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
[TBL] [Abstract][Full Text] [Related]
39. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
[TBL] [Abstract][Full Text] [Related]
40. Non-surgical treatment of hidradenitis suppurativa: the role of cryotherapy.
Dell'Antonia M; Anedda J; Tatti A; Falco A; Sanna S; Ferreli C; Atzori L
Front Med (Lausanne); 2023; 10():1141691. PubMed ID: 37144039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
